AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy
Drug manufacturer AstraZeneca today sent letters to 340B covered entities and its wholesale pharmacy contacts telling them that, effective Oct. 1, it
…Drug manufacturer AstraZeneca today sent letters to 340B covered entities and its wholesale pharmacy contacts telling them that, effective Oct. 1, it
…A Message from Publisher and CEO Ted Slafsky: I encourage you all to read today’s sponsored content article from SPARx, a division of Comprehensive Pharmacy Services, about the importance of relationships with key stakeholders in hospital-based specialty pharmacy. The ability
…The U.S. Health and Human Services Department (HHS) should halt drug manufacturers Eli Lilly and Merck’s recent separate actions to curtail or
…A Message from Publisher and CEO Ted Slafsky: We recently welcomed FQHC 340B Compliances Services to our growing list of sponsors. In today’s sponsored content article, FQHC 340B Lead Consultant Michael Gonzalez offers five great tips on how covered entities can
…A note from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Click on the button
…A note from 340B Report CEO and Publisher Ted Slafsky: Please join us in welcoming Comprehensive Pharmacy Services to our growing group of 340B Report sponsors! And I hope you enjoy a new column from
…A note from 340B Report CEO and Publisher Ted Slafsky: I encourage all of you to read Trellis Rx Chief Pharmacy Officer Jerry Buller’s great article in today’s issue about how 340B health systems can leverage
…The U.S. Justice Department is suing drug manufacturer Mallinckrodt for allegedly
…In theory, federal law and 340B program guidance should protect 340B entities from shouldering an unfair
…*Sign up for news summaries and alerts from 340B Report